mPEG-PDLLA Micelles Potentiate Docetaxel for Intraperitoneal Chemotherapy in Ovarian Cancer Peritoneal Metastasis.

Front Pharmacol · 2022 · PMC9019464 · PMID 35462938

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In the negative control groups, in which NS was administered to the animals, the body weight changes showed a trend to increase first and then decrease after 12 days as the tumors were left untreated.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.